Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis.

Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis.

Changes in the airway microbiome may be important in the pathophysiology of chronic lung disease in patients with cystic fibrosis. However, little is known about the microbiome in early cystic fibrosis lung disease and the relationship between the microbiomes from different niches in the upper and l...

Full description

Bibliographic Details
Main Authors:	Sébastien Boutin, Simon Y Graeber, Michael Weitnauer, Jessica Panitz, Mirjam Stahl, Diana Clausznitzer, Lars Kaderali, Gisli Einarsson, Michael M Tunney, J Stuart Elborn, Marcus A Mall, Alexander H Dalpke
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4309611?pdf=render

Similar Items

A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis
by: Marisa I. Metzger, et al.
Published: (2021-12-01)

Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis
by: Dario L. Frey, et al.
Published: (2022-05-01)

Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
by: Buqing Yi, et al.
Published: (2021-03-01)

Commensal Bacteria in the Cystic Fibrosis Airway Microbiome Reduce P. aeruginosa Induced Inflammation
by: Andrew Tony-Odigie, et al.
Published: (2022-01-01)

Community analysis and co-occurrence patterns in airway microbial communities during health and disease
by: Gisli G. Einarsson, et al.
Published: (2019-07-01)

Multi-Omics Approaches: The Key to Improving Respiratory Health in People With Cystic Fibrosis?
by: Andrew J. Lee, et al.
Published: (2020-09-01)

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
by: Linus Piehler, et al.
Published: (2023-04-01)

The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
by: Anthony A Fodor, et al.
Published: (2012-01-01)

Reduced bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis.
by: Katherine O'Neill, et al.
Published: (2015-01-01)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
by: Caitlyn Harvey, et al.
Published: (2022-03-01)

In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis
by: Michael M Tunney, et al.
Published: (2024-03-01)

Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years
by: Julian Berges, et al.
Published: (2023-05-01)

Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens
by: Deirdre F. Gilpin, et al.
Published: (2019-12-01)

Culture enriched molecular profiling of the cystic fibrosis airway microbiome.
by: Christopher D Sibley, et al.
Published: (2011-01-01)

Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions.
by: Gerard McCaughey, et al.
Published: (2013-01-01)

Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis
by: Mirjam Stahl, et al.
Published: (2021-05-01)

Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis
by: Jacob Vieira, et al.
Published: (2022-10-01)

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease
by: Eva Steinke, et al.
Published: (2023-01-01)

Nuclear localization of Suppressor of Cytokine Signaling (SOCS)-1 regulates local immunity in the lung
by: Jana Zimmer, et al.
Published: (2016-11-01)

Modulator treatment for people with cystic fibrosis: moving in the right direction
by: J. Stuart Elborn
Published: (2020-03-01)

Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor Lungs
by: Gisli G. Einarsson, et al.
Published: (2022-03-01)

Pseudomonas aeruginosa Modulates the Antiviral Response of Bronchial Epithelial Cells
by: Michael Sörensen, et al.
Published: (2020-02-01)

Corrigendum: Pseudomonas aeruginosa Modulates the Antiviral Response of Bronchial Epithelial Cells
by: Michael Sörensen, et al.
Published: (2020-07-01)

Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis
by: Simon Y. Graeber, et al.
Published: (2021-05-01)

Comparative evaluation of the effect of different growth media on in vitro sensitivity to azithromycin in multi-drug resistant Pseudomonas aeruginosa isolated from cystic fibrosis patients
by: Michael Sörensen, et al.
Published: (2020-12-01)

Dental Biofilm and Saliva Microbiome and Its Interplay with Pediatric Allergies
by: Nicole B. Arweiler, et al.
Published: (2021-06-01)

Insights into the Adolescent Cystic Fibrosis Airway Microbiome Using Shotgun Metagenomics
by: Gillian McDermott, et al.
Published: (2024-03-01)

Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity
by: Andrea Hahn, et al.
Published: (2018-09-01)

The airway microbiome of persons with cystic fibrosis correlates with acquisition and microbiological outcomes of incident Stenotrophomonas maltophilia infection
by: Lauren A. Bowron, et al.
Published: (2024-04-01)

Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population
by: Michael D. Parkins, et al.
Published: (2011-04-01)

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging
by: Lena Wucherpfennig, et al.
Published: (2023-04-01)

Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study
by: Andrea Hahn, et al.
Published: (2020-04-01)

Impact of lockdown during the COVID-19 pandemic on health status in patients with cystic fibrosis: a mono-centre observational study
by: Stephanie Thee, et al.
Published: (2022-03-01)

Early Cytokine Induction Upon Pseudomonas aeruginosa Infection in Murine Precision Cut Lung Slices Depends on Sensing of Bacterial Viability
by: Ulrike Kolbe, et al.
Published: (2020-10-01)

Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections
by: Ad C. Fluit, et al.
Published: (2022-05-01)

Meta-analysis Reveals Potential Influence of Oxidative Stress on the Airway Microbiomes of Cystic Fibrosis Patients
by: Xing Shi, et al.
Published: (2019-12-01)

Untargeted Metagenomic Investigation of the Airway Microbiome of Cystic Fibrosis Patients with Moderate-Severe Lung Disease
by: Giovanni Bacci, et al.
Published: (2020-07-01)

Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis
by: Gabriella Shumyatsky, et al.
Published: (2023-01-01)

Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation.
by: Mariana E Kirst, et al.
Published: (2019-01-01)

Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome Diversity
by: Andrea Hahn, et al.
Published: (2018-05-01)